Clover Health Investments, Corp. (CLOV)

Market Cap	1.31B
Revenue (ttm)	1.77B
Net Income (ttm)	-58.32M
Shares Out	516.68M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	161.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,157,863
Open	2.630
Previous Close	2.620
Day's Range	2.525 - 2.680
52-Week Range	2.120 - 4.870
Beta	2.13
Analysts	Buy
Price Target	3.35 (+31.89%)
Earnings Date	Feb 26, 2026

About CLOV

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could. The company is based in Wilmington, Delaware.

• Industry: Healthcare Plans
• Sector: Healthcare
• Founded: 2014
• Employees: 570
• Stock Exchange: NASDAQ
• Ticker Symbol: CLOV
• Website: https://www.cloverhealth.com

Financial Performance

In 2024, Clover Health Investments's revenue was $1.37 billion, an increase of 8.52% compared to the previous year's $1.26 billion. Losses were -$43.01 million, -79.84% less than in 2023.

Analyst Summary

According to 2 analysts, the average rating for CLOV stock is "Buy." The 12-month stock price target is $3.35, which is an increase of 31.89% from the latest price.

Price Target

$3.35

(31.89% upside)

Analyst Consensus: Buy